Table 5.

Adverse drug reactions of artemisinin combination therapies among P. falciparum patients (9 studies included)

No.	Drug used in the study	Number of studies mentioned ADRs as drug related	Frequency (%) of patients with ADRs relevant to specific treatment regimen
1	Artemether–Lumefantrine (AL)	5	88/1263 (6.9%)
2	Artesunate–Amodiaquine (AS+AQ)	5	69/1574 (4.4%)
3	Dihydroartemisinin–Piperaquine (DP)	2	5/273 (1.8%)
4	Artesunate-Sulphamethoxypyrazine-Pyrimethamine (AS+SMP)	1	3/250 (1.2%)
5	Pyronaridine:artesunate (PA) (tab & granule)	1	7/30 (23.3%)
6	Chlorproguanil-dapsone-artesunate (CDA)	1	184/914 (20.1%)
	Total		356/4304 (8.3%)